news

The expanded use of ustekinumab addresses a high unmet need among children with moderate to severe plaque psoriasis, aged 6–11

LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext: POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic

– Risdiplam demonstrated statistically significant and medically meaningful motor milestone improvement in infants with Type 1 SMA – – No

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of

LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global heparin market since 2015 and the market is poised to grow by USD

— Phase 3 trial achieved its primary endpoint and all secondary endpoints with marked improvement in key indicators of disease

WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of

WASHINGTON–(BUSINESS WIRE)–#GovWaste–Today, Citizens Against Government Waste (CAGW) named California Governor Gavin Newsom our January 2020 Porker of the Month for

CEO Sandy Solmon to Present on Celavie’s Stem Cell Therapies at Upcoming Conferences in New York and Barcelona OXNARD, Calif.–(BUSINESS

CEO Sandy Solmon to Present on Celavie’s Stem Cell Therapies at Upcoming Conferences in New York and Barcelona OXNARD, Calif.–(BUSINESS